Pediatricians across the Mid-South say upper respiratory infections are surging right now, especially among young children.

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Pregnant women who get the RSV shot late in the pregnancy can pass along the antibodies to their infant. This is an option ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

experiences with all 3 of her children. Now she's trying to warn others about RSV. (Photo: Gabrielle Hopkins Photography/Courtesy of Shawn Johnson East) As a 2007 World Champion and 2008 Olympic ...

Abrysvo is now approved for adults aged 18-59 years at increased risk for RSV due to chronic conditions, expanding its previous indications. The FDA's decision is based on a phase 3 trial showing ...

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

(NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF ...

New real-world data suggests that seniors who get the RSV vaccine have an 80% lower odds for severe illness It's yet another reason to get immunized ahead of another RSV season Widespread immunization ...

RSV is a significant public health concern for vulnerable populations, especially the elderly and newborns. Researchers estimate that nearly every child will be infected by the age of two. While ...

Three months after revealing that its respiratory syncytial virus (RSV) preventive antibody clesrovimab had passed muster in a phase 2b/3 trial, Merck is putting numbers to the claim. Clesrovimab ...